Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction

Lei Wang; Min-zhou Zhang; Guang Yang

doi:10.1007/s11655-009-0233-6

Your Location：

Home >

Browse articles >

Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction

Updated：2021-08-27

- Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction
- Chinese Journal of Integrative Medicine Vol. 15, Issue 3, Pages: 233-235(2009)
- Affiliations：
  
  Heart Center, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou,China
- Author bio：
- Funds：
  
  Supported by Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P.R. China (No. 200707004)
- DOI：10.1007/s11655-009-0233-6
  CLC：
- Published：2009，
  
  Published Online：2 July 2009，
Scan for full text
Wang, L., Zhang, Mz. & Yang, G. Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction., Chin. J. Integr. Med. 15, 233–235 (2009). https://doi.org/10.1007/s11655-009-0233-6

Lei Wang, Min-zhou Zhang, Guang Yang. Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction. [J]. Chinese Journal of Integrative Medicine 15(3):233-235(2009)
Wang, L., Zhang, Mz. & Yang, G. Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction., Chin. J. Integr. Med. 15, 233–235 (2009). https://doi.org/10.1007/s11655-009-0233-6 DOI：

Lei Wang, Min-zhou Zhang, Guang Yang. Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction. [J]. Chinese Journal of Integrative Medicine 15(3):233-235(2009) DOI： 10.1007/s11655-009-0233-6.

摘要

There are not enough clinical data about centenarians with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). A 104-year-old woman exhibited sharp chest pain and severe dyspnea. In routine examinations

her electrocardiogram showed 1–3 mm ST-segment elevation from V1 to V4 leads

the cardiac enzymes were also elevated: creatine kinase (CK)-MB was 45.7 U/L

and cardiac specific troponin I was 40 μg/L. A two-dimensional echocardiography showed anteroseptal akinesia with severely depressed left ventricular function

38% ejection fraction. She primarily refused to receive percutaneous coronary intervention (PCI) considering her old age

and she was given a dual anti-platelet medications (low molecular heparin and frusemide). Three days later

due to continuously deteriorating angina pectoris and dyspnea

she was treated with PCI. A diagnostic percutaneous transradial coronary angiography revealed 95% stenosis in the proximal left anterior descending artery (LAD) with 90% stenosis at the origin of diagonal one. A percutaneous coronary intervention for the LAD lesion was successfully performed

and the final angiogram showed a good coronary flow without residual stenosis. The dual anti-platelet medications had to be ceased due to the upper gastrointestinal bleeding after one week and Tongguan Capsule (通冠胶囊

Chinese medicine composed with Radix Astragali

Radix Salviae Miltiorrhiae

etc.) was administered continuously. The six-month follow-up displayed a high level quality of life for the centenarian woman with the absence of angina pectoris and dyspnea. The case reinforces the importance of PCI for very elderly patients with AMI even centenarian people and reveals the possibility that Tongguan Capsule can be used to replace dual anti-platelet medication with the reduction of bleeding complications.

Abstract

her electrocardiogram showed 1–3 mm ST-segment elevation from V1 to V4 leads

the cardiac enzymes were also elevated: creatine kinase (CK)-MB was 45.7 U/L

and cardiac specific troponin I was 40 μg/L. A two-dimensional echocardiography showed anteroseptal akinesia with severely depressed left ventricular function

38% ejection fraction. She primarily refused to receive percutaneous coronary intervention (PCI) considering her old age

and she was given a dual anti-platelet medications (low molecular heparin and frusemide). Three days later

due to continuously deteriorating angina pectoris and dyspnea

Chinese medicine composed with Radix Astragali

Radix Salviae Miltiorrhiae

关键词

acute myocardial infarctionPercutaneous Coronary InterventionChinese Medicinecentenarian

Keywords

acute myocardial infarctionPercutaneous Coronary InterventionChinese Medicinecentenarian

references

He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353:1124–1134.

Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:588–636.

Valente S, Lazzeri C, Salvadori C, Chiostri M, Giglioli C, Poli S, et al. Effectiveness and safety of routine primary angioplasty in patients aged > or =85 years with acute myocardial infarction. Circ J 2008;72:67–70.

Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, et al. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years. Chin Med J (Engl) 2006;119:1151–1156.

Skolnick AH, Alexander KP, Chen AY, Roe MT, Pollack CJ, Ohman EM, et al. Characteristics, management, and outcomes of 5,557 patients age >90 years with acute coronary syndromes. JACC 2007;49:1790–1797.

Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-Lapointe NM, et al. CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 2005;294:3108–3116.

Zhang XW, Zhang MZ. Effect of Tongguan Capsule on coagulant and fibrinolysis system in patients with coronary heart disease after percutaneous coronary intervention. Chin J Integr Tradit West Med (Chin) 2004;24:1065–1068.

Cao AQ, Tian WJ, Li Song. The influence of Tongguan Capsule on contents of GMP-140 and vWF of patients with coronary heart disease after PCI. Chin J Integr Med Cardio-/Cerebrovas Dis 2004;2:685–686.

FULL TEXT LINK

More>

Views

355

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Clinical efficacy of traditional chinese medicine on acute myocardial infarction—A prospective cohort study

Shi Da-zhuo (史大卓) —An outstanding cardiologist of integrative medicine

Thinking on treatment of post-reperfusion events in patients with coronary heart disease by integrated traditional Chinese and Western medicine

Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial

Huoxue Anxin Recipe (活血安心方) promotes myocardium angiogenesis of acute myocardial infarction rats by up-regulating miR-210 and vascular endothelial growth factor

Related Author

No data

Related Institution

Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences

National Integrative Medicine Center for Cardiovascular Disease, China-Japan Friendship Hospital, Ministry of Public Health

Institute of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Department of Gastroenterology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Department of Cardiovascular, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰